IsoPlexis is building solutions to accelerate the development of curative medicines and personalized therapeutics.

Register for Details

For more details on financing and valuation for IsoPlexis, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about IsoPlexis

Forge green plus iconForge green minus icon

What is IsoPlexis's IPO price?

IsoPlexis's IPO price is $0.741 as of 3/17/23.
Forge green plus iconForge green minus icon

What is IsoPlexis's funding to date?

IsoPlexis has raised $161.52MM to date.
Forge green plus iconForge green minus icon

When was IsoPlexis founded?

IsoPlexis was founded in 2013.

IsoPlexis Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
1/7/2021 Series D $92.5MM raised $XXX.XX $XXX.XX
1/9/2020 Series C and C-2 $50MM raised $XXX.XX $XXX.XX
9/26/2017 Series B and B-2 $13.68MM raised $XXX.XX $XXX.XX
5/28/2015 Series A-2 $3.69MM raised $XXX.XX $XXX.XX
7/6/2014 Series A $1.65MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Nov 15, 2023


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.